12th September 2013

New SVANOVIR® SBV-Ab - 3 clear advantages in serologic Schmallenberg Virus testing

The Swedish veterinary diagnostic company Boehringer Ingelheim SVANOVA is pleased to announce the launch of a new ELISA kit for the detection of antibodies against Schmallenberg Virus (SBV).

SVANOVIR® SBV-Ab provides accurate confirmation of exposure to Schmallenberg Virus with 3 clear advantages for laboratories. First, the multispecies format allows testing of cattle, sheep and goats in one assay. Second, both serum and milk samples can be analysed, and third, the SVANOVIR® SBV-Ab shows stronger performance figures compared to competitor assays. The assay is thoroughly validated in cooperation with the Swedish National Veterinary Institute (SVA), providing a useful tool in serologic investigations in Schmallenberg Virus infections.

Schmallenberg Virus, an Orthobunyavirus, was first detected in 2011 in Germany. Among others, cattle and small ruminants are susceptible and this vector-borne disease has already spread to large parts of Europe since its discovery. The prevalence is high and the induced immunity seems to be long lasting. Clinical signs in adult ruminants are often absent, mild, or unspecific, and include reduction of milk yield, fever, dullness, mild diarrhea, abortions and/or malformed offspring.

Extensive prevalence studies in many European countries have already been done, but many aspects of Schmallenberg Virus infection are still unclear. Testing is ongoing and further spread of the infection is likely (Wernike et al., 2013).